Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway.

BAF180 Von Hippel-Lindau germline mutation clear cell renal cell carcinoma hypoxia inducible factor 1 hypoxia inducible factor 2 polybromo 1 somatic mutation von Hippel-Lindau disease

Journal

Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 25 05 2021
accepted: 03 08 2021
entrez: 29 10 2021
pubmed: 30 10 2021
medline: 30 10 2021
Statut: ppublish

Résumé

Von Hippel-Lindau (VHL) disease is the main cause of inherited clear-cell renal cell carcinoma (ccRCC) and is caused by germline mutations in the

Identifiants

pubmed: 34712359
doi: 10.3892/ol.2021.13096
pii: OL-22-06-13096
pmc: PMC8548775
doi:

Types de publication

Journal Article

Langues

eng

Pagination

835

Informations de copyright

Copyright: © Gad et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Front Oncol. 2018 Jun 08;8:214
pubmed: 29938199
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
J Clin Oncol. 2004 Dec 15;22(24):4991-5004
pubmed: 15611513
Semin Cancer Biol. 2013 Feb;23(1):18-25
pubmed: 22705278
Am J Med Genet A. 2021 Aug;185(8):2576-2581
pubmed: 33973706
Eur Urol. 2016 Oct;70(4):623-632
pubmed: 26707870
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1027-1032
pubmed: 28082722
Cell Rep. 2017 Mar 21;18(12):2893-2906
pubmed: 28329682
Am J Surg Pathol. 2013 Oct;37(10):1490-504
pubmed: 24025520
Neoplasia. 2019 Feb;21(2):247-256
pubmed: 30660076
Cell. 2018 Apr 19;173(3):611-623.e17
pubmed: 29656891
Cell Res. 2011 Mar;21(3):396-420
pubmed: 21358755
Cancer Res. 2009 Jun 1;69(11):4674-81
pubmed: 19470766
Oncogenesis. 2017 Jan 16;6(1):e287
pubmed: 28092369
Int J Oncol. 2018 Oct;53(4):1455-1468
pubmed: 30066860
Cancer Cell. 2002 Jun;1(5):459-68
pubmed: 12124175
Cancer Cell. 2008 Dec 9;14(6):435-46
pubmed: 19061835
J Clin Oncol. 2018 Oct 29;:JCO2018792549
pubmed: 30372397
Nat Med. 2020 Oct;26(10):1519-1530
pubmed: 33020645
Nat Commun. 2020 Aug 17;11(1):4111
pubmed: 32807776
PLoS One. 2016 Oct 20;11(10):e0164554
pubmed: 27764136
Urol Oncol. 2015 Aug;33(8):340.e9-16
pubmed: 26003625
Semin Cancer Biol. 2013 Feb;23(1):26-37
pubmed: 22659535
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Genes Chromosomes Cancer. 2014 Jan;53(1):38-51
pubmed: 24166983
J Clin Oncol. 2018 Oct 29;:JCO2018791905
pubmed: 30372394
J Urol. 1998 Oct;160(4):1248-54
pubmed: 9751329
Genome Biol. 2014 Aug 27;15(8):433
pubmed: 25159823
J Med Genet. 2015 Jun;52(6):426-30
pubmed: 25911086
Nat Genet. 2012 Jun 10;44(7):751-9
pubmed: 22683710
Nature. 2010 Jan 21;463(7279):360-3
pubmed: 20054297
Nature. 2011 Jan 27;469(7331):539-42
pubmed: 21248752
PLoS One. 2016 Apr 21;11(4):e0153718
pubmed: 27100670

Auteurs

Sophie Gad (S)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.
Mixed Research Unit (UMR) 9019, Gustave Roussy Institute, French National Scientific Research Center (CNRS), Paris-Saclay University, 94800 Villejuif, France.

Gwenaël Le Teuff (G)

Department of Biostatistics and Epidemiology, Gustave Roussy Institute, CNRS, Paris-Saclay University, 94800 Villejuif, France.
French National Health and Medical Research Institute (INSERM), Research Center in Epidemiology and Population Health (CESP), Paris-Saclay School of Medicine, Paris-Saclay University, 94800 Villejuif, France.

Baptiste Nguyen (B)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.

Virginie Verkarre (V)

Department of Pathology, Public Hospitals of Paris (AP-HP) Centre, Georges Pompidou European Hospital, Paris University, 75015 Paris, France.
INSERM UMR 970, Paris Cardiovascular Research Center (PARCC), Georges Pompidou European Hospital, 75015 Paris, France.
Department of Urology, PREDIR French National Cancer Institute (INCa), AP-HP, Bicêtre Hospital, 94270 Le Kremlin-Bicêtre, France.

Veronique Duchatelle (V)

Department of Pathology, Saint-Joseph Hospital, 75014 Paris, France.

Vincent Molinie (V)

Department of Pathology, Saint-Joseph Hospital, 75014 Paris, France.
Department of Pathology, Aix-en-Provence Hospital Center, 13616 Aix en Provence, France.

Katia Posseme (K)

Department of Pathology, AP-HP, Bicêtre Hospital, Paris-Saclay University, 94270 Le Kremlin-Bicêtre, France.

Benjamin Grandon (B)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.

Melanie Da Costa (M)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.

Bastien Job (B)

Bioinformatics Core Facility, Gustave Roussy Institute, CNRS, Paris-Saclay University, 94800 Villejuif, France.

Guillaume Meurice (G)

Bioinformatics Core Facility, Gustave Roussy Institute, CNRS, Paris-Saclay University, 94800 Villejuif, France.

Nathalie Droin (N)

Genomics Core Facility, Gustave Roussy Institute, CNRS, Paris-Saclay University, 94800 Villejuif, France.

Arnaud Mejean (A)

Department of Urology, PREDIR French National Cancer Institute (INCa), AP-HP, Bicêtre Hospital, 94270 Le Kremlin-Bicêtre, France.
Department of Urology, AP-HP, Georges Pompidou European Hospital, Paris University, 75015 Paris, France.

Sophie Couve (S)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.
Mixed Research Unit (UMR) 9019, Gustave Roussy Institute, French National Scientific Research Center (CNRS), Paris-Saclay University, 94800 Villejuif, France.

Flore Renaud (F)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.
Mixed Research Unit (UMR) 9019, Gustave Roussy Institute, French National Scientific Research Center (CNRS), Paris-Saclay University, 94800 Villejuif, France.

Betty Gardie (B)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.
L'Institut du Thorax, INSERM, CNRS, Nantes University, 44000 Nantes, France.

Bin Tean Teh (BT)

Program in Cancer and Stem Cell Biology, Duke-National University of Singapore (NUS) Medical School, Singapore 169610, Republic of Singapore.
Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre, Singapore 169610, Republic of Singapore.

Stephane Richard (S)

Ecole Pratique des Hautes Etudes (EPHE), Paris Sciences Lettres Research University, 75014 Paris, France.
Mixed Research Unit (UMR) 9019, Gustave Roussy Institute, French National Scientific Research Center (CNRS), Paris-Saclay University, 94800 Villejuif, France.
Department of Urology, PREDIR French National Cancer Institute (INCa), AP-HP, Bicêtre Hospital, 94270 Le Kremlin-Bicêtre, France.

Sophie Ferlicot (S)

Mixed Research Unit (UMR) 9019, Gustave Roussy Institute, French National Scientific Research Center (CNRS), Paris-Saclay University, 94800 Villejuif, France.
Department of Urology, PREDIR French National Cancer Institute (INCa), AP-HP, Bicêtre Hospital, 94270 Le Kremlin-Bicêtre, France.
Department of Pathology, AP-HP, Bicêtre Hospital, Paris-Saclay University, 94270 Le Kremlin-Bicêtre, France.

Classifications MeSH